Results 141 to 150 of about 131,409 (188)
Safety and Pharmacokinetics of SRN001, a Novel siRNA Drug Targeting Amphiregulin via the SAMiRNA Platform. [PDF]
Park J +6 more
europepmc +1 more source
Canagliflozin treatment reshapes the gut microbiota in DKD and elevates levels of melibiose, a metabolite derived from Roseburia intestinalis. Melibiose directly binds to and enhances the enzymatic activity of glyoxalase 1, leading to decreased methylglyoxal accumulation.
Wei Zhang +32 more
wiley +1 more source
Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society. [PDF]
Lonsdale DO +5 more
europepmc +1 more source
ABSTRACT Genome‐wide association studies (GWAS) link the Tropomyosin 1 (Tpm1) locus to quantitative blood trait variation, but related mechanisms are unclear. Tpm1 encodes an actin‐binding protein that regulates actin filament diversity, cell adhesion, signaling, and actomyosin contractility.
Po‐Lun Kung +19 more
wiley +1 more source
Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network. [PDF]
Jayachandran P +13 more
europepmc +1 more source
Nanocellulose, derived from microcrystalline cellulose (MCC) through sulfuric acid hydrolysis or mechanical grinding to produce CNC or CNF, was tested in a rat ICP model. Particularly, CNF improved gut microbiota composition, reduced secondary bile acid metabolism, and restored bile acid homeostasis through modulation of the gut–liver axis.
Muhua Yu +18 more
wiley +1 more source
Celebrating the 65th Anniversary of the Journal of Clinical Pharmacology. [PDF]
van den Anker J.
europepmc +1 more source
Corrigendum to: "Astrocytic glutamate transporter 1 (GLT1) deficient mice exhibit repetitive behaviors" [Behav. Brain Res. 396 (2021) 112906]. [PDF]
Jia YF +4 more
europepmc +1 more source
Population Pharmacokinetic Analysis of MIT-001, a Novel Ferroptosis Inhibitor, for Dose Optimization. [PDF]
Bae S +5 more
europepmc +1 more source

